Kolexia
Tournigand Christophe Médecine interne
Tournigand Christophe
Médecine interne
Hôpital Henri Mondor
Créteil, France
461 Activités
1.3 K Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Carcinomes Adénocarcinome Métastase tumorale Tumeurs du côlon Tumeurs du pancréas Instabilité des microsatellites Tumeurs de l'estomac Tumeurs du sein

Collaborateurs

Voir plus
Andre Thierry
Andre Thierry
Hôpital Saint-Antoine, Paris, France
Louvet Christophe
Louvet Christophe
Institut Mutualiste Montsouris, Paris, France
Rousseau Benoit
Rousseau Benoit
Hôpital Henri Mondor, Créteil, France
Bachet Jean Baptiste
Bachet Jean Baptiste
Hôpital Pitie Salpetriere, Paris, France

Industries

Voir plus
MSD
9 collaboration(s)
Dernière en 2023
Bayer
8 collaboration(s)
Dernière en 2023
Servier
5 collaboration(s)
Dernière en 2023
Novartis
5 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
STRATEGIC-1: Multi-Line Therapy Trial in Unresectable Wild-Type RAS Metastatic Colorectal Cancer. A GERCOR Randomized Open-label Phase III Study.
Essai Clinique (Roche)   08 mars 2024
A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley): A Phase II, Multicenter, Randomized, Open Label, Parallel-Arm, Umbrella Study of Avelumab (MSB0010718C) in Combination With Other AntiTumor Agents as a Maintenance Treatment in Participants With Locally Advanced or Metastatic Urothelial Carcinoma Whose Disease Did Not Progress With First Line Platinum-Containing Chemotherapy (JAVELIN Bladder Medley)
Essai Clinique (Emd Serono)   05 février 2024
RePERSO: Evaluation of Treatment PERSOnalization Based on Its Therapeutic Monitoring in Patients With Metastatic Colorectal Cancer Treated With REgorafenib
Essai Clinique (CHU Rennes)   30 janvier 2024
Impact of the Sars-Cov-2 outbreak on the initial clinical presentation of new solid cancer diagnoses: a systematic review and meta-analysis.
BMC cancer   29 janvier 2024
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care.
British journal of cancer   25 janvier 2024
Prognostic and Predictive Markers of Response to Treatment in Patients With Bile Duct Cancer: ACABi PRONOBIL Study: Marqueurs Pronostiques et prédictifs de réponse Aux Traitements Chez Les Patients Atteints de Cancer Des Voies Biliaires : Cohorte Multicentrique ACABi PRONOBIL
Essai Clinique (GERCOR (Multidisciplinary Group in Oncology))   03 janvier 2024
IMMUNO-BIL: Durvalumab Plus Tremelimumab Combination Immunotherapy With or Without Weekly Paclitaxel in Patients With Advanced Biliary Tract Carcinoma (BTC) After Failure of Platinum-based Chemotherapy: a Randomized Non-comparative Two-arm Phase II Study
Essai Clinique (AstraZeneca)   03 janvier 2024
REPROGRAM-02: Induction Regorafenib in Combination With Metronomic Cyclophosphamide, Capecitabine, and Low-dose Aspirin Followed by Chemotherapy in Second Line Metastatic Colorectal Cancer Carcinoma An Open-label Randomized Phase II-III Study
Essai Clinique (CHU Besançon)   21 décembre 2023
Effect of Adapted Physical Activity in Patients With Advanced Pancreatic Cancer: The APACaP GERCOR Randomized Trial.
Journal of the National Comprehensive Cancer Network : JNCCN   16 décembre 2023
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma.
Nature communications   14 décembre 2023